EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Third-generation cephalosporin-induced L-form transition in Shigella sonnei reveals a virulence-survival trade-off underlying persistent infection

Sanjib Das, Arindam Mukherjee, Prolay Halder, Soumalya Banerjee, Supriya Mandal, Nivedita Roy, Ashis Debnath, Sreejani Banerjee, Manjistha Manna, Upama Mandal, Jiro Mitobe, Jeffrey H Withey iD und 4 weitere

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.02246-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Sanjib Das und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Bacteriology, ICMR-National Institute for Research in Bacterial Infections, Beliaghata, Kolkata, India. Hauptthemen laut MEDLINE: Shigella sonnei, Dysentery, Bacillary, Anti-Bacterial Agents, Third Generation Cephalosporins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UGC, India, ICMR-National Institute for Research in Bacterial Infections, Kolkata, National Institute of Infectious Diseases, Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Shigellosis remains a major global health burden, and the increasing prevalence of multidrug-resistant (MDR) Shigella strains is complicating effective antibiotic therapy. Bacteria may survive antibiotics by transitioning into cell wall-deficient L-forms, which are intrinsically resistant to β-lactams and can revert to a virulent state, potentially causing relapsing infections. Here, we characterized a clinical MDR isolate Shigella sonnei HK8, a.k.a. PD552A, whose genome contains key resistance ( gyrA , PBP3) and virulence ( icsA ) genes. Exposure to ceftriaxone induced a transition into a viable L-form state that was hyper-adhesive to macrophages in vitro . However, this survival adaptation was linked to a profound loss of pathogenicity. Using murine and guinea pig models, the L-form variant was shown to be severely attenuated, failing to cause keratoconjunctivitis, diarrheal disease, or significant histopathology characteristic of the wild-type strain. These findings reveal a critical virulence-survival trade-off, positioning the L-form as a “stealth” phenotype that enables bacterial persistence at the expense of acute virulence. This offers a potential mechanism for asymptomatic carriage and recurrent infections, highlighting a previously underappreciated mechanism by which antibiotic treatment may resolve acute symptoms while permitting the persistence of a cryptic bacterial reservoir capable of driving recurrent infection. IMPORTANCE Our research provides critical insight into the challenge of antibiotic treatment failure in shigellosis. By integrating experimental validation of reversible L-form transitions with mathematical modeling, we uncover a crucial virulence-survival trade-off. We show that multidrug-resistant Shigella sonnei survives ceftriaxone by adopting a “stealth” phenotype, quantified by a high stealth index—maintaining bacterial burden while evading host inflammatory detection. These findings imply that standard antibiotics may resolve acute symptoms while inadvertently selecting for a cryptic, persistent reservoir poised for relapse. This work challenges the conventional view of therapeutic success and highlights an urgent need to develop novel diagnostic and therapeutic strategies capable of identifying and eliminating these resilient, “stealth” L-form persisters to achieve true bacterial clearance and prevent chronic infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shigella sonneiDysentery, BacillaryAnti-Bacterial AgentsThird Generation CephalosporinsPersistent InfectionAnimalsVirulenceMiceGuinea PigsDrug Resistance, Multiple, BacterialHumansMacrophagesDisease Models, AnimalCeftriaxoneFemale

Stichwörter der Autor:innen

L-form bacteriaShigella sonneianimal modelsceftriaxonechronic infection

Substanzen

Anti-Bacterial AgentsThird Generation CephalosporinsCeftriaxone

Autor:innen und Institutionen

  • Division of Bacteriology, ICMR-National Institute for Research in Bacterial Infections, Beliaghata, Kolkata, India.
  • Department of Bacteriology, National Institute of Infectious Diseases (NIID), Tokyo, Japan.
  • Department of Biochemistry, Microbiology and Immunology, Wayne State University School of Medicine, Detroit, Michigan, USA.

ORCID-Profile: Jeffrey H Withey, Asish Kumar Mukhopadhyay, Debaki Ranjan Howlader, Hemanta Koley

Förderung

  • UGC, India
  • ICMR-National Institute for Research in Bacterial Infections, Kolkata
  • National Institute of Infectious Diseases, Japan
  • DBT, India

Zitieren

APA

Das, S., Mukherjee, A., Halder, P., Banerjee, S., Mandal, S., Roy, N., Debnath, A., Banerjee, S., Manna, M., Mandal, U., Mitobe, J., Withey, J. H., Mukhopadhyay, A. K., Das, S., Howlader, D. R., & Koley, H. (2026). Third-generation cephalosporin-induced L-form transition in Shigella sonnei reveals a virulence-survival trade-off underlying persistent infection. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02246-25

Vancouver

Das S, Mukherjee A, Halder P, Banerjee S, Mandal S, Roy N, et al. Third-generation cephalosporin-induced L-form transition in Shigella sonnei reveals a virulence-survival trade-off underlying persistent infection. Microbiology Spectrum. 2026. doi:10.1128/spectrum.02246-25

BibTeX
@article{Das2026,
  author = {Das, Sanjib and Mukherjee, Arindam and Halder, Prolay and Banerjee, Soumalya and Mandal, Supriya and Roy, Nivedita and Debnath, Ashis and Banerjee, Sreejani and Manna, Manjistha and Mandal, Upama and Mitobe, Jiro and Withey, Jeffrey H and Mukhopadhyay, Asish Kumar and Das, Santasabuj and Howlader, Debaki Ranjan and Koley, Hemanta},
  title = {Third-generation cephalosporin-induced L-form transition in Shigella sonnei reveals a virulence-survival trade-off underlying persistent infection},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.02246-25}
}
Kostenlos starten →